LCN2, a neutrophil gelatinase-associated lipocalin, is a small glycosylated protein that is regarded as a biomarker of acute kidney injury and is thought to associate with chronic kidney disease progression in humans [40–43]. Here, LCN2 is linked to chronic kidney disease.